Phase 2 Study of Daratumumab in Relapsed/Refractory...

  • Main
  • 2019 / 1
  • Phase 2 Study of Daratumumab in Relapsed/Refractory...
Clinical Lymphoma Myeloma and Leukemia 2019 / 1

Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma

Salles, Gilles, Gopal, Ajay K., Minnema, Monique C., Wakamiya, Karen, Feng, Huaibao, Schecter, Jordan M., Wang, Michael
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2018.12.013
Date:
January, 2019
File:
PDF, 794 KB
english, 2019
Conversion to is in progress
Conversion to is failed